Cytosorbents Capital Lease Obligations from 2010 to 2024

CTSO Stock  USD 0.93  0.01  1.06%   
Cytosorbents Crp Capital Lease Obligations yearly trend continues to be very stable with very little volatility. Capital Lease Obligations is likely to drop to about 9.3 M. Capital Lease Obligations is the total obligations of Cytosorbents Crp under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. View All Fundamentals
 
Capital Lease Obligations  
First Reported
2019-03-31
Previous Quarter
13.3 M
Current Value
13.2 M
Quarterly Volatility
6.2 M
 
Covid
Check Cytosorbents Crp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytosorbents main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 150 K or Selling General Administrative of 39.8 M, as well as many exotic indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.002 or PTB Ratio of 2.24. Cytosorbents financial statements analysis is a perfect complement when working with Cytosorbents Crp Valuation or Volatility modules.
  
This module can also supplement Cytosorbents Crp's financial leverage analysis and stock options assessment as well as various Cytosorbents Crp Technical models . Check out the analysis of Cytosorbents Crp Correlation against competitors.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

Latest Cytosorbents Crp's Capital Lease Obligations Growth Pattern

Below is the plot of the Capital Lease Obligations of Cytosorbents Crp over the last few years. Cytosorbents Crp capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Cytosorbents Crp asset purchases. For example, Cytosorbents Crp can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Cytosorbents Crp control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Cytosorbents Crp's Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytosorbents Crp's overall financial position and show how it may be relating to other accounts over time.
Capital Lease Obligations10 Years Trend
Slightly volatile
   Capital Lease Obligations   
       Timeline  

Cytosorbents Capital Lease Obligations Regression Statistics

Arithmetic Mean4,094,458
Geometric Mean2,046,540
Coefficient Of Variation129.06
Mean Deviation4,440,306
Median1,070,762
Standard Deviation5,284,510
Sample Variance27.9T
Range12.8M
R-Value0.73
Mean Square Error13.9T
R-Squared0.54
Significance0
Slope867,295
Total Sum of Squares391T

Cytosorbents Capital Lease Obligations History

20249.3 M
202313.3 M
202213.3 M
202113.8 M
2020M

About Cytosorbents Crp Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Cytosorbents Crp income statement, its balance sheet, and the statement of cash flows. Cytosorbents Crp investors use historical funamental indicators, such as Cytosorbents Crp's Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although Cytosorbents Crp investors may use each financial statement separately, they are all related. The changes in Cytosorbents Crp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cytosorbents Crp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cytosorbents Crp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cytosorbents Crp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Lease Obligations13.3 M9.3 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:
Check out the analysis of Cytosorbents Crp Correlation against competitors.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Cytosorbents Stock analysis

When running Cytosorbents Crp's price analysis, check to measure Cytosorbents Crp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytosorbents Crp is operating at the current time. Most of Cytosorbents Crp's value examination focuses on studying past and present price action to predict the probability of Cytosorbents Crp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytosorbents Crp's price. Additionally, you may evaluate how the addition of Cytosorbents Crp to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Cytosorbents Crp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.59)
Revenue Per Share
0.776
Quarterly Revenue Growth
0.036
Return On Assets
(0.33)
Return On Equity
(1.15)
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.